跳至主要内容
临床试验/DRKS00004209
DRKS00004209已完成不适用

Age-effects in the determinants of performance, nutrition and health in track and field Master Athletes and control subjects - MAC

Deutsches Zentrum für Luft- und RaumfahrtInstitut für Luft- und RaumfahrtmedizinWeltraumphysiologie0 个研究点目标入组 100 人开始时间: 2013年1月7日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
35 Years 至 110 Years(—)
性别
All

入选标准

  • There are individual criteria for each test:
  • 1. Jump and hopping tests: Any master athlete
  • 2. Heat exchange, oxygen delivery and consumption limitations of muscle function: Any Master Athlete.
  • 3. Blood samples for determination of oxidative stress, systemic inflammation, lipoprotein profile, glucose, insulin:Any Master Athlete
  • 4. Muscle Biopsy (Biopsy): Any master athlete
  • 5. Follow-up of bone density measurements (pQCT): Athletes who have already participated in our pQCT-study in the past
  • 6. Sarcopenia: Any master athlete
  • 7. Resting metabolic rate: Any master athlete
  • 8. Incidence of injuries and medical emergencies in master athletes during competition: Any master athlete with an injury during the competition
  • 9. Muscle Biopsy Control group (DLR Cologne):No regular training for a specific sport on a competition level. As this is a control group, participants will be matched with the athletes.

排除标准

  • There are individual criteria for each test:
  • 1. Jump and hopping tests: none
  • 2. Heat exchange, oxygen delivery and consumption limitations of muscle function: Neuromuscular disorders
  • Cardiovascular history including:
  • oprevious myocardial infarction
  • oprevious stroke
  • oknown cardiac valve insufficiencies
  • oarrhythmias
  • major surgery in the last two years
  • organ transplants
  • 3. Blood samples for determination of oxidative stress, systemic inflammation, lipoprotein profile, glucose, insulin:Increased bleeding tendency (hemophilia, regular use of anticoagulants)
  • 4. Muscle Biopsy (Biopsy): Increased bleeding tendency (hemophilia, regular use of anticoagulants), history of intolerance to local anesthetics, neuromuscular disorders, cardiovascular history including:
  • oprevious myocardial infarction
  • oprevious stroke
  • oknown cardiac valve insufficiencies
  • oarrhythmias
  • major surgery in the last two years
  • organ transplants
  • 5. Follow-up of bone density measurements (pQCT): Athletes who have not participated in our study in the past, pregnant athletes
  • 6. Sarcopenia: Athletes with a cardiac pacemaker or an implantable cardioverter defibrillator
  • 7. Resting metabolic rate: none
  • 8. On location: Incidence of injuries and medical emergencies in master athletes during competition: none
  • 9. Muscle Biopsy Control group (DLR Cologne): As this is a control group, participants will be matched with the athletes. Otherwise same exclusion criteria as in test station 3.

研究者

发起方
Deutsches Zentrum für Luft- und RaumfahrtInstitut für Luft- und RaumfahrtmedizinWeltraumphysiologie

相似试验